Luvixasertib (hydrochloride)
CFI-402257 hydrochloride is a highly selective and orally bioavailable TTK/Mps1 inhibitor with an IC50 of 1.7 nM for TTK in vitro. CFI-402257 hydrochloride has anti-cancer activity[1].
Product Specifications
CAS Number
[1610677-37-6]
Product Name Alternative
CFI-402257 (hydrochloride)
UNSPSC
12352005
Target
Mps1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cfi-402257-hydrochloride.html
Purity
99.63
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC(C2=C3N=C(OC4=CN=CC=C4)C=C(NC[C@@H]5C[C@@](O)(C)C5)N3N=C2)=CC=C1C(NC6CC6)=O.Cl
Molecular Formula
C28H31ClN6O3
Molecular Weight
535.04
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Citation 01
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items